Literature DB >> 962876

The identification of 2,8-dihydroxyadenine, a new component of urinary stones.

H A Simmonds, K J Van Acker, J S Cameron, W Snedden.   

Abstract

Stones passed by a child homozygous for a deficiency of the enzyme adenine phosphoribosyltransferase have been identified by u.v., i.r. and mass spectrometry as 2,8-dihydroxyadenine.

Entities:  

Mesh：

Substances：

Year:  1976        PMID： 962876      PMCID： PMC1163876          DOI： 10.1042/bj1570485

Source DB:  PubMed          Journal:  Biochem J        ISSN： 0264-6021            Impact factor:   3.857


  8 in total

1.  8-Hydroxyadenine as the intermediate in the oxidation of adenine to 2, 8-dihydroxyadenine by xanthine oxidase.

Authors:  J B WYNGAARDEN; J T DUNN
Journal:  Arch Biochem Biophys       Date:  1957-07       Impact factor: 4.013

2.  Two dimensional thin-layer high-voltage electrophoresis and chromatography for the separation of urinary purines, pyrimidines and pyrazolopyrimidines.

Authors:  H A Simmonds
Journal:  Clin Chim Acta       Date:  1969-02       Impact factor: 3.786

3.  Histopathological studies on kidneys from patients treated with large amounts of blood preserved with ACD-adenine.

Authors:  J S Falk; G T Lindblad; B J Westman
Journal:  Transfusion       Date:  1972 Nov-Dec       Impact factor: 3.157

4.  The occurrence and binding of 2,8-dioxyadenine in plasma.

Authors:  I J Stern; F Cosmas; P J Garvin
Journal:  Transfusion       Date:  1972 Nov-Dec       Impact factor: 3.157

5.  [Purine phosphoribosyltransferase activity of human erythrocytes. Technic of determination].

Authors:  P Cartier; M Hamet
Journal:  Clin Chim Acta       Date:  1968-05       Impact factor: 3.786

6.  Urinary excretion of purines, pyrimidines and pyrazolopyrimidines in patients treated with allopurinol or oxipurinol.

Authors:  H A Simmonds
Journal:  Clin Chim Acta       Date:  1969-02       Impact factor: 3.786

7.  [A new metabolic disease: the complete deficit of adenine phosphoribosyltransferase and lithiasis of 2,8-dihydroxyadenine].

Authors:  P Cartier; M Hamet; J Hamburger
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1974-09

8.  The conversion of 4-hydroxypyrazolo[3,4-d]pyrimidine (allopurinol) into 4,6-dihroxypyrazolo[3,4-d]pyrimidine (Oxipurinol) in vivo in the absence of xanthine-oxen oxidoreductase.

Authors:  R A Chalmers; R Parker; H A Simmonds; W Snedden; R W Watts
Journal:  Biochem J       Date:  1969-05       Impact factor: 3.857
  8 in total
  20 in total

Review 1.  Special aspects of stone composition and aetiology of different types of urinary calculi.

Authors:  A Hesse; W D Miersch
Journal:  Int Urol Nephrol       Date:  1989       Impact factor: 2.370

Review 2.  Heberden oration 1979: human aberrations of purine metabolism and their significance for rheumatology.

Authors:  J E Seegmiller
Journal:  Ann Rheum Dis       Date:  1980-04       Impact factor: 19.103

3.  APT1, but not APT2, codes for a functional adenine phosphoribosyltransferase in Saccharomyces cerevisiae.

Authors:  J D Alfonzo; T R Crother; M L Guetsova; B Daignan-Fornier; M W Taylor
Journal:  J Bacteriol       Date:  1999-01       Impact factor: 3.490

4.  Purine metabolism in lymphocytes from patients with primary hypogammaglobulinaemia.

Authors:  A D Webster; M North; J Allsop; G L Asherson; R W Watts
Journal:  Clin Exp Immunol       Date:  1978-03       Impact factor: 4.330

5.  Proceedings of a symposium on crystal-related arthropathies. 22 October and 23 October, 1982, Bristol Polytechnic, Bristol.

Authors: 
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

Review 6.  Human purine metabolism: some recent advances and relationships with immunodeficiency.

Authors:  G Nuki
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

7.  A multiple technique approach to the analysis of urinary calculi.

Authors:  A L Rodgers; L R Nassimbeni; K J Mulder
Journal:  Urol Res       Date:  1982

8.  Selection of human cells having two different types of mutations in individual cells (genetic/artificial mutants). Application to the diagnosis of the heterozygous state for a type of adenine phosphoribosyltransferase deficiency.

Authors:  N Kamatani; S Kuroshima; C Terai; K Kawai; K Mikanagi; K Nishioka
Journal:  Hum Genet       Date:  1987-06       Impact factor: 4.132

9.  Human adenine phosphoribosyltransferase. Identification of allelic mutations at the nucleotide level as a cause of complete deficiency of the enzyme.

Authors:  Y Hidaka; T D Palella; T E O'Toole; S A Tarlé; W N Kelley
Journal:  J Clin Invest       Date:  1987-11       Impact factor: 14.808

Review 10.  Gout, uric acid and purine metabolism in paediatric nephrology.

Authors:  J S Cameron; F Moro; H A Simmonds
Journal:  Pediatr Nephrol       Date:  1993-02       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.